Investor

Quintiles

Last cheque observed Apr 2013. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietCorporate VC

Series DSeries ESeries ABiotechnologyHealth CarePharmaceutical

Cheques on record
0%of best year0cheques in 12 months, 6 on record
Since the last cheque4955days00hrs00min00sec
Median round$32MRounds led0 of 6Exits2 from the portfolioMostly inUnited States, 100%
Pitch Quintiles

Quintiles highlights

  1. 01

    6 rounds on record

  2. 02

    Mostly Series D and Series E: 67% of its rounds

  3. 03

    2 exits from the portfolio

What they do

Type
Corporate VC (from a list, unverified)
Cheque size
Not stated
Sectors
BiotechnologyHealth CarePharmaceutical
Cold pitches
Not stated

The record

Every round we can evidence, newest first6 appearances

  1. 2013

    1 round

  2. Apr
    Revance TherapeuticsSeries E · US · biocentury.com$33MWith 2 others
  3. 2011

    2 rounds

  4. Jun
    Revance TherapeuticsSeries D · US · finsmes.com$45MWith 6 others
  5. Jun
    Ambit BiosciencesSeries D · US · phx.corporate-ir.net$30MWith 9 others
  6. 2010

    1 round

  7. Jul
    Artisan PharmaSeries C · US · masshightech.com$3.0MWith 4 others
  8. 2006

    1 round

  9. Sept
    Artisan PharmaSeries A · US · artisanpharma.net$39MWith 4 others
  10. 2001

    1 round

  11. Jun
    NitroMedSeries E · US$31MWith 6 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

Exits from the portfolio

Companies it backed that were later bought or listed2 in all

Ambit BiosciencesBought by Daiichi Sankyo$410MSept 2014
Artisan PharmaBought by Asahi Kasei PharmaUndisclosedNov 2011

An exit counts when it came after the firm's first round in the company. From historical deal records.

Companies it bought

Acquisitions by the firm itself

Targeted Molecular DiagnosticsUndisclosedDec 2008

Who they invest alongside

The investors most often in the same rounds as Quintiles. A count of rooms they were both in, not a relationship either has claimed.

Bio*One CapitalCorporate VC2rounds togetherEssex Woodlands Healthcare PartnersVC firm2rounds togetherJafco VenturesGrowth equity2rounds togetherNGN CapitalVC firm2rounds togetherNew Leaf Venture PartnersVC firm2rounds together

Quick answers about Quintiles

What does Quintiles invest in?

Quintiles invests most often at Series D and Series E (67% of the rounds on record), in sectors such as Biotechnology, Health Care and Pharmaceutical.

How active is Quintiles?

6 investments on record, 0 of them in the last 12 months. The most recent was in Apr 2013.

How big are Quintiles's cheques?

The median round it joins is $32M.

Does Quintiles lead rounds?

Rarely, if at all: none of its 6 investments on record names it as the lead.

Where does Quintiles invest?

Most of the companies it backs are in the United States (100%).

Is Quintiles investing now?

No investments in the last 12 months; the latest was in Apr 2013.

Who does Quintiles invest alongside?

Most often Bio*One Capital (2 rounds together), Essex Woodlands Healthcare Partners (2 rounds together) and Jafco Ventures (2 rounds together).

What kind of investor is Quintiles?

Quintiles is a corporate VC.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it